5 High Growth UK Stocks to Buy

Page 1 of 5

In this piece, we will take a look at five high growth U.K. stocks to buy. For more stocks, head on over to 11 High Growth U.K. Stocks to Buy.

5. Adaptimmune Therapeutics plc (NASDAQ:ADAP)

Q/Q Sales Growth: 483%

Number of Hedge Fund Holders in Q4 2022: 22

Adaptimmune Therapeutics plc (NASDAQ:ADAP) is a biotechnology firm that develops tumor and cancer treatments. Some cancers that the firm is taking aim at include those of the lungs, head, and neck. The company is based in Abingdon, United Kingdom.

Adaptimmune Therapeutics plc (NASDAQ:ADAP) had a bumper third quarter of fiscal 2022 ending in September that saw it post $7 million in revenue for an outlandish 483% annual growth. By the end of December 2022, 22 of the 943 hedge funds polled by Insider Monkey had invested in the company.

Adaptimmune Therapeutics plc (NASDAQ:ADAP)’s largest shareholder in our database is David Goel and Paul Ferri’s Matrix Capital Management which owns 38 million shares that are worth $56 million.

Follow Adaptimmune Therapeutics Plc (NASDAQ:ADAP)



Page 1 of 5